| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $14.5M | — | -31.3% |
| Cost of Revenue | $8.9M | — | -49.8% |
| Gross Profit | $5.6M | — | +67.2% |
| R&D Expense | $611K | — | -20.6% |
| SG&A Expense | $4.4M | — | -22.9% |
| Operating Income | -$3.4M | — | +52.6% |
| Pre-tax Income | -$17.6M | — | -157.1% |
| Net Income | -$17.7M | — | -243.4% |
| EPS (Basic) | -$0.18 | — | -28.6% |
| EPS (Diluted) | -$0.18 | — | -28.6% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $10.7M | +22.4% | -41.6% |
| Current Assets | $38.8M | +74.9% | +50.5% |
| Total Assets | $68.2M | -14.0% | +0.6% |
| Current Liabilities | $44.5M | +8.9% | -1.5% |
| Total Liabilities | $48.7M | +11.6% | -14.9% |
| Stockholders' Equity | $17.7M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$6.4M | — | +25.2% |
| Capital Expenditures | $3K | — | -95.8% |
| Investing Cash Flow | -$2.5M | — | -570.5% |
| Financing Cash Flow | $6.7M | — | +360.2% |
| Free Cash Flow | -$6.4M | — | +25.8% |
| +68.7% |